We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6323:TSERorze Corporation Analysis

Data as of 2026-05-18 - not real-time

¥3,672.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The 20‑day SMA sits comfortably above the 50‑day and 200‑day averages, signaling a broad‑based bullish framework. However, the price is trading below the 20‑day SMA, indicating short‑term weakness. The RSI hovers around the midpoint, suggesting no immediate overbought pressure. MACD remains in bearish territory with a negative histogram, reinforcing the near‑term downside bias. Volume has been on a decreasing trend, which may limit upside momentum. A high 30‑day volatility reading and a beta above one point three underscore heightened price swings. The current market price sits well above the DCF‑derived fair value, pointing to an overvalued valuation.
Fundamentally, the company delivers solid gross and operating margins despite a modest revenue contraction. Cash on hand far exceeds debt, and the debt‑to‑equity ratio remains low, providing a strong balance‑sheet cushion. Return on equity is in the double‑digit range, indicating efficient capital deployment. The dividend payout is modest, supporting dividend sustainability. Analyst consensus leans toward a strong‑buy, and the market sentiment index reflects “Extreme Greed,” suggesting optimism may be pricing in future growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below short‑term SMA
  • bearish MACD histogram
  • declining volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • bullish SMA alignment across timeframes
  • strong cash position
  • low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • valuation above DCF fair value
  • sustained dividend
  • moderate sector cyclicality

Key Metrics & Analysis

Financial Health

Revenue Growth-2.40%
Profit Margin14.79%
P/E Ratio33.6
ROE13.02%
ROA10.10%
Debt/Equity17.00
P/B Ratio4.9
Op. Cash Flow¥31.2B
Free Cash Flow¥22.1B
Industry P/E38.2

Technical Analysis

TrendBullish
RSI50.4
Support¥3,491.00
Resistance¥4,210.00
MA 20¥3,790.45
MA 50¥3,293.77
MA 200¥2,587.42
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value¥1,941.87
Target Price¥4,550.00
Upside/Downside23.91%
GradeOvervalued
TypeGrowth
Dividend Yield0.54%

Risk Assessment

Beta1.34
Volatility85.77%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.